Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: A prospective study

The Lancet Respiratory Medicine

Volumn 4, Issue 1, 2016, Pages 49-58

  Pankhurst, Louise J ^a   del Ojo Elias, Carlos ^a   Votintseva, Antonina A ^a   Walker, Timothy M ^a   Cole, Kevin ^d   Davies, Jim ^c   Fermont, Jilles M ^b   Gascoyne Binzi, Deborah M ^f   Kohl, Thomas A ^j,k   Kong, Clare ⁱ   Lemaitre, Nadine ^g   Niemann, Stefan ^j,k,l   Paul, John ^d   Rogers, Thomas R ^b,m   Roycroft, Emma ^b,m   Smith, E Grace ^e   Supply, Philip ^g,h   Tang, Patrick ⁱ   Wilcox, Mark H ^f   Wordsworth, Sarah ^b   Wyllie, David ^a,c   Xu, Li ^e   Crook, Derrick W ^a   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UK   (United Kingdom)

^e UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^f LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^g UNIV LILLE   (France)

^h Genoscreen   (France)

ⁱ British Columbia Centres for Disease Control Public Health   (Canada)

^j RESEARCH CENTER BORSTEL   (Germany)

^k German Center for Infection Research   (Germany)

^l ST JAMES S HOSPITAL   (Ireland)

^m PUBLIC HEALTH ENGLAND   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BIOINFORMATICS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST; CULTURE MEDIUM; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EUROPE; FEASIBILITY STUDY; GENE MAPPING; GENE SEQUENCE; GENETIC DISTANCE; HUMAN; INTERMETHOD COMPARISON; LABORATORY DEVICE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NORTH AMERICA; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; PROCESSING TIME; PROSPECTIVE STUDY; SEQUENCE HOMOLOGY; TUBERCULOSIS; UNITED KINGDOM; WHOLE GENOME SEQUENCING; CANADA; COHORT ANALYSIS; DNA SEQUENCE; EARLY INTERVENTION; ECONOMICS; FRANCE; GENETICS; GERMANY; IRELAND; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM; TIME FACTOR; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; CANADA; COHORT STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EARLY MEDICAL INTERVENTION; FRANCE; GERMANY; HUMANS; IRELAND; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; TIME FACTORS; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; UNITED KINGDOM;

EID: 84952979528     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(15)00466-X     Document Type: Article

References (32)

1. Global tuberculosis report 2015, WHO, World Health Organization, Geneva.
2. van Ingen J, Bendien SA, de Lange WC, et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, the Netherlands. Thorax 2009, 64:502-506.
3. Paynter S, Hayward A, Wilkinson P, Lozewicz S, Coker R Patient and health service delays in initiating treatment for patients with pulmonary tuberculosis: retrospective cohort study. Int J Tuberc Lung Dis 2004, 8:180-185.
4. Anderson LF, Tamne S, Brown T, et al. Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing. Lancet Infect Dis 2014, 14:406-415.
5. Didelot X, Bowden R, Wilson DJ, Peto TE, Crook DW Transforming clinical microbiology with bacterial genome sequencing. Nat Rev Genet 2012, 13:601-612.
6. Feuerriegel S, Schleusener V, Beckert P, et al. PhyResSE: a web tool delineating Mycobacterium tuberculosis antibiotic resistance and lineage from whole-genome sequencing data. J Clin Microbiol 2015, 53:1908-1914.
7. Parrish N, Carrol K Importance of improved TB diagnostics in addressing the extensively drug-resistant TB crisis. Future Microbiol 2008, 3:405-413.
8. Coll F, McNerney R, Preston MD, et al. Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences. Genome Med 2015, 7:51.
9. Witney AA, Gould KA, Arnold A, et al. Clinical application of whole-genome sequencing to inform treatment for multidrug-resistant tuberculosis cases. J Clin Microbiol 2015, 53:1473-1483.
10. Casali N, Nikolayevskyy V, Balabanova Y, et al. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat Genet 2014, 46:279-286.
11. Clark TG, Mallard K, Coll F, et al. Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencing. PLoS One 2013, 8:e83012.
12. Koser CU, Bryant JM, Becq J, et al. Whole-genome sequencing for rapid susceptibility testing of M tuberculosis. N Engl J Med 2013, 369:290-292.
13. Walker TM, Ip CL, Harrell RH, et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 2013, 13:137-146.
14. Walker TM, Lalor MK, Broda A, et al. Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007-12, with whole pathogen genome sequences: an observational study. Lancet Respir Med 2014, 2:285-292.
15. Walker TM, Kohl TA, Omar SV, et al. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis 2015, 15:1193-1202.
16. Gardy JL, Johnston JC, Ho Sui SJ, et al. Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N Engl J Med 2011, 364:730-739.
17. Roetzer A, Diel R, Kohl TA, et al. Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study. PLoS Med 2013, 10:e1001387.
18. Eldholm V, Monteserin J, Rieux A, et al. Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain. Nat Commun 2015, 6:7119.
19. Guerra-Assuncao JA, Crampin AC, Houben RM, et al. Large-scale whole genome sequencing of M tuberculosis provides insights into transmission in a high prevalence area. Elife 2015, 4:e05166.
20. Votintseva AA, Pankhurst LJ, Anson LW, et al. Mycobacterial DNA extraction and whole-genome sequencing from early positive liquid (MGIT) cultures. J Clin Microbiol 2015, 53:1137-1143.
21. Royston P, Sauerbrei W Multivariable model-building: a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables 2008, Wiley, Chichester.
22. March, 2015. Annual TB update 2015 Public Health England, (accessed Nov 17, 2015). https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/415540/Annual_TB_update_2015.pdf.
23. Cain JA, Solis N, Cordwell SJ Beyond gene expression: the impact of protein post-translational modifications in bacteria. J Proteomics 2014, 97:265-286.
24. Siddiqi N, Das R, Pathak N, et al. Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump. Infection 2004, 32:109-111.
25. Xie L, Liu W, Li Q, et al. First succinyl-proteome profiling of extensively drug-resistant Mycobacterium tuberculosis revealed involvement of succinylation in cellular physiology. J Proteome Res 2015, 14:107-119.
26. Horne DJ, Pinto LM, Arentz M, et al. Diagnostic accuracy and reproducibility of WHO-endorsed phenotypic drug susceptibility testing methods for first-line and second-line antituberculosis drugs. J Clin Microbiol 2013, 51:393-401.
27. Fricke WF, Rasko DA Bacterial genome sequencing in the clinic: bioinformatic challenges and solutions. Nat Rev Genet 2014, 15:49-55.
28. March 5, 2015. Whole genome sequencing (WGS) program US Food and Drug Administration, (accessed July 2, 2015). http://www.fda.gov/Food/FoodScienceResearch/WholeGenomeSequencingProgramWGS.
29. Hasnain SE, O'Toole RF, Grover S, Ehtesham NZ Whole genome sequencing: a new paradigm in the surveillance and control of human tuberculosis. Tuberculosis 2015, 95:91-94.
30. Lecuit M, Eloit M The diagnosis of infectious diseases by whole genome next generation sequencing: a new era is opening. Front Cell Infect Microbiol 2014, 4:25.
31. Drobniewski F, Cooke M, Jordan J, et al. Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis. Health Technol Assess 2015, 19:1-188.
32. Brown AC, Bryant JM, Einer-Jensen K, et al. Rapid whole-genome sequencing of Mycobacterium tuberculosis isolates directly from clinical samples. J Clin Microbiol 2015, 53:2230-2237.